Confirming a KIT mutation and assessing disease spread are critical initial steps for GIST management. Understanding the mutational profile helps tailor treatment, as some mutations may resist Gleevec ...

Combining surgery with chemotherapy significantly improves survival in GIST patients with liver metastases compared to chemotherapy alone. Median CSS and OS for combined treatment exceed 120 months, ...

The optimal duration of adjuvant imatinib has yet to be determined, and clinical trials are ongoing to address this. KIT-directed tyrosine kinase inhibitors (TKIs) are the key treatment for advanced ...

Mixed liposarcoma: A study of socioeconomic and demographic factors. 5-year overall survival rates by time period and stage for GIST and STS.

A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has introduced a new, multi-omics-based molecular classification of these tumors ...